JENNER VACCINE FOUNDATION

Charity overview
Activities - how the charity spends its money
The aims of the Foundation are to undertake research and development aimed at the creation, testing and deployment of new vaccines against diseases of humans and livestock. The Foundation will have a particular focus on vaccines of the developing world where greatest needs exist for novel vaccines.
Income and expenditure
Data for financial year ending 31 March 2024
People

8 Trustee(s)
Employees with total benefits over £60,000
No information availableFundraising
Trading
Trustee payments
What, who, how, where
- Education/training
- The Advancement Of Health Or Saving Of Lives
- The General Public/mankind
- Makes Grants To Organisations
- Sponsors Or Undertakes Research
- Bracknell Forest
- Oxfordshire
- Reading
- Slough
- West Berkshire
- Windsor And Maidenhead
- Wokingham
Governance
- 28 November 1995: Standard registration
- THE EDWARD JENNER INSTITUTE FOR VACCINE RESEARCH (Previous name)
- Conflicting interests
- Investment
Trustees
Trustees are the people responsible for controlling the work, management and administration of the charity on behalf of its beneficiaries. Generally trustees are treasurer, chair, board member etc. The trustees are responsible for keeping this list up to date and can do this by updating their details as they happen through the online service
8 Trustee(s)
Name | Role | Date of appointment | Other trusteeships | Reporting status of other trusteeships | ||||
---|---|---|---|---|---|---|---|---|
Dr Jan Theunis Poolman | Trustee | 17 July 2023 |
|
|
||||
Professor Helen Alison Fletcher | Trustee | 03 July 2019 |
|
|
||||
Professor Gavin Robert Screaton | Trustee | 03 July 2019 |
|
|
||||
Dr Michael James Francis | Trustee | 01 September 2016 |
|
|
||||
Professor Venugopal Nair | Trustee | 02 February 2016 |
|
|
||||
Dr Bryan Charleston | Trustee | 09 December 2013 |
|
|
||||
PROFESSOR DAVID MAXWELL SALISBURY | Trustee | 31 January 2012 |
|
|
||||
PROF ANDREW POLLARD | Trustee |
|
|
Financial history
Financial period end date
Income / Expenditure | 31/03/2020 | 31/03/2021 | 31/03/2022 | 31/03/2023 | 31/03/2024 | ||
---|---|---|---|---|---|---|---|
|
Total gross income | £12.86k | £9.59k | £14.26k | £15.48k | £21.37k | |
|
Total expenditure | £46.95k | £20.00k | £34.75k | £43.20k | £44.69k | |
|
Income from government contracts | N/A | N/A | N/A | N/A | N/A | |
|
Income from government grants | N/A | N/A | N/A | N/A | N/A |
Accounts and annual returns
Title | Reporting year | Date received | Received | Download |
---|---|---|---|---|
Annual return | 31 March 2024 | 10 January 2025 | On Time | |
Accounts and TAR | 31 March 2024 | Not Required | ||
Annual return | 31 March 2023 | 31 January 2024 | On Time | |
Accounts and TAR | 31 March 2023 | Not Required | ||
Annual return | 31 March 2022 | 04 May 2023 | 93 days late | |
Accounts and TAR | 31 March 2022 | Not Required | ||
Annual return | 31 March 2021 | 31 January 2022 | On Time | |
Accounts and TAR | 31 March 2021 | Not Required | ||
Annual return | 31 March 2020 | 29 January 2021 | On Time | |
Accounts and TAR | 31 March 2020 | Not Required |
Governing document
It is not the full text of the charity's governing document.
MEMORANDUM AND ARTICLES OF ASSOCIATION INCORPORATED 14/7/1995 AS AMENDED 1/11/2005.
Charitable objects
THE ADVANCEMENT OF EDUCATION AND IN PARTICULAR EDUCATION RESEARCH AND TRAINING IN THE FIELDS OF IMMUNOLOGY AND INFECTIOUS MALIGNANT OR OTHER CHRONIC DISEASES OR RELATED FIELDS OF MEDICINE SCIENCE AND TECHNOLOGY FOR THE DISCOVERY OR CREATION OF STRATEGIES FOR NOVEL VACCINES FOR THE PUBLIC BENEFIT
Area of benefit
NOT DEFINED - IN PRACTICE BERKSHIRE
Contact information
- Address:
-
Finance Division
University of Oxford
Oxford University Press
Great Clarendon Street
Oxford
OX2 6DP
- Phone:
- 01865 616160
- Email:
- sophie.pryor@admin.ox.ac.uk
Tell us whether you accept cookies
We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.
We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.
Thank you for your feedback. Do you have 5 minutes to tell us what you think of this service?Open in new window